ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
Project Title | Institution / Principal Investigator(s) |
Grant Type![]() |
Year | State |
---|---|---|---|---|
Dissecting the role and mechanism of MLLT10 fusion proteins to treat pediatric leukemia | The Trustees of the University of Pennsylvania / Kathy Fange Liu, Ph.D. | R Accelerated Award Grants | 2024 | Pennsylvania |
Uridine is a Targetable Metabolic Dependency in Acute Lymphoblastic Leukemia | Board of Trustees of the Leland Stanford Junior University / Kara Davis, D.O. | R Accelerated Award Grants | 2024 | California |
Widening the therapeutic index for pediatric medulloblastoma by targeting BET proteins | Harvard University / Kristopher Sarosiek, Ph.D. | R Accelerated Award Grants | 2024 | Massachusetts |
Therapeutic targeting of clonal hematopoiesis in RUNX1 mutant FPDMM | University of Pennsylvania / Robert Bowman, Ph.D. | RARE Grant Program (Research Accelerating RUNX1 Exploration) | 2024 | Pennsylvania |
Translating sarcoma antigen-directed co-stimulatory NK cells to the clinic | Baylor College of Medicine / Robin Parihar | Reach Grants | 2024 | Texas |
Overcoming Menin-inhibitor resistance | Children’s Hospital of Philadelphia / Kathrin Bernt, MD | Reach Grants | 2024 | Pennsylvania |
Exploring the Interplay of Microbiome, Bile Acids, Immune Reconstitution, and Clinical Outcomes Following Allogeneic Hematopoietic Transplantation in Pediatrics | Memorial Sloan-Kettering Cancer Center / Oriana Miltiadous, MD | Reach Grants | 2024 | New York |
Translating sarcoma antigen-directed co-stimulatory NK cells to the clinic | Baylor College of Medicine / Robin Parihar, MD/PhD | Reach Grants | 2024 | Texas |
IGFBPL1 Peptide-Centric Chimeric Antigen Receptor Autologous T Cells for Relapsed HLA-A*02 Neuroblastoma and Medulloblastoma | Children’s Hospital of Philadelphia / John Maris, MD | Reach Grants | 2024 | Pennsylvania |
Collective cell invasion of fusion positive rhabdomyosarcoma regulated by PAX3-FOXO1 | Children’s Hospital Los Angeles / Jinseok Park, PhD | 'A' Award Grants | 2024 | California |